🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the drug there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could result in users administering substances of uncertain source.

Some experts stated the popularity for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and customer regulations, risking penalties, legal action or prison.

Service Reaction and Content Elimination

According to the social media company, the service has removed violative material and prohibited related keywords and query recommendations. The company stated it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, positive testimonials and step-by-step guides for mixing or administering at residence.

After minutes of entering one community, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.

Product Details and Pricing

Within these communities, posts display dark colored parcels with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service stated it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they cannot confirm. Even if the research behind this drug is valid, these online products may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental substance not yet approved … may subject patients to possibly significant health risks”.